PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 44 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,500 | -24.8% | 100,000 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $11,300 | -31.5% | 100,000 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $16,500 | +52.8% | 100,000 | 0.0% | 0.01% | +50.0% |
| Q4 2022 | $10,800 | +116.0% | 100,000 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $5,000 | -16.7% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | -14.3% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $7,000 | +16.7% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,000 | -14.3% | 100,000 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $7,000 | 0.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | 0.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | +16.7% | 100,000 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $6,000 | -33.3% | 100,000 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $9,000 | +125.0% | 100,000 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $4,000 | -20.0% | 100,000 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $5,000 | -16.7% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | -14.3% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $7,000 | +16.7% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $6,000 | 0.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $6,000 | +20.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,000 | -28.6% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $7,000 | 0.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $7,000 | +16.7% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $6,000 | -25.0% | 100,000 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $8,000 | +166.7% | 100,000 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $3,000 | 0.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $3,000 | -25.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $4,000 | +100.0% | 100,000 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $2,000 | -80.0% | 100,000 | 0.0% | 0.00% | -83.3% |
| Q3 2016 | $10,000 | -73.0% | 100,000 | 0.0% | 0.01% | -72.7% |
| Q2 2016 | $37,000 | -2.6% | 100,000 | 0.0% | 0.02% | -8.3% |
| Q1 2016 | $38,000 | -2.6% | 100,000 | 0.0% | 0.02% | -7.7% |
| Q4 2015 | $39,000 | – | 100,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,226,961 | $824,000 | 0.12% |
| HOME FEDERAL BANK OF TENNESSEE | 100,000 | $37,000 | 0.02% |
| Cutter & CO Brokerage, Inc. | 84,500 | $31,000 | 0.01% |
| PRINCETON CAPITAL MANAGEMENT LLC | 10,000 | $4,000 | 0.01% |
| WADE G W & INC | 80,000 | $30,000 | 0.01% |
| Estate Counselors, LLC | 10,000 | $4,000 | 0.00% |
| SABBY MANAGEMENT, LLC | 93,283 | $35,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11,466 | $4,000 | 0.00% |
| ACADEMY CAPITAL MANAGEMENT INC/TX | 20,000 | $6,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 27,451 | $10,000 | 0.00% |